Healthcare & Medical

Immuno-Oncology Summit 2025

The 13th Annual 2025 Immuno-Oncology Summit brings together professionals in life sciences, pharmaceuticals, clinical research, healthcare, and IT to discuss advances in the development of immune-oncology therapeutics for solid tumors. The conference showcases preclinical and clinical successes grounded in deep biological understanding, including innovations…

Visit the official siteRegister
10Speakers
4Sponsors
0On the bill · sessions
14Companies · in total
§I

Speakers

Programmed at Immuno-Oncology, in alphabetical order.
Biao Zheng, PhD
CEO · BRL Medicine
Carter Caldwell, MBA
Co-Investment Program Director · University of Pennsylvania
David Sommerhalder, MD
Clinical Investigator, Oncology · NEXT Oncology
Karen Chagin, MD
Senior Vice President, Early Stage Development · Adaptimmune
Kristen Meerbrey, PhD
Director of Target Discovery, Therapeutic Innovation Center · Baylor College of Medicine
Margery Ma, PhD
Principal Consultant, NonClinical Regulatory Affairs · Eliquent Life Sciences
Rakesh Dixit, PhD, DABT
President & Founder · Bionavigen Oncology, LLC and Regio Biosciences
Shameer Khader, PhD
Executive Director, Global Head of Data Science, Data Engineering and Computational Biology · Sanofi
Tatiana Novobrantseva, PhD
CSO · NextPoint Therapeutics
Vitalay Fomin, PhD
Co-Founder · Numenos AI
§II

Sponsors

The houses behind the program. Tiers as disclosed.
IRBM
Mispro
Nona Biosciences
Wuxi App Tec
Intermission
Part the Second · For the Buyer

An audience of 14 companies, parsed from the program.

Fourteen companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
0All threespeak · spons · exh
4Sponsoringsponsor only
10Companies Speakingspeaker only
Speakers by seniority

70% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite110%
  • Founder / Owner220%
  • VP-level110%
  • Director / Head of330%
  • Manager / Lead110%
  • Other roles220%

Of 10 on the bill · classified by free-text title

Most-represented companies
  1. 01IRBMSp
  2. 02MisproSp
  3. 03Nona BiosciencesSp
  4. 04WuXi AppTecSp
  5. 05Adaptimmune1V
  6. 06Baylor College of Medicine1V
  7. 07Bionavigen Oncology, LLC and Regio Biosciences1V
  8. 08BRL Medicine1V
  9. 09Eliquent Life Sciences1V
  10. 10NEXT Oncology1V
  11. 11NextPoint Therapeutics1V
  12. 12Numenos AI1V
  13. 13Sanofi1V
  14. 14University of Pennsylvania1V
Sponsors by tier
unspecified4
100% of 4